category,datetime,headline,id,image,related,source,summary,url
company,1769256682,How Investors May Respond To Bio-Techne (TECH) Doubling Down On Multi-Omic Integration Under New Leadership,138245215,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,TECH,Yahoo,"Earlier in 2026, Bio-Techne highlighted its leadership in spatial biology and proteomic analysis under new CEO Kim Kelderman, emphasizing automated diagnostic platforms and multi-omic integration, while also scheduling a February 4, 2026 conference call to review second-quarter fiscal 2026 results. An interesting angle is managementâ€™s emphasis on operational integration and cross-selling across spatial biology, proteomics, and cell and gene therapy tools, supported by a balance sheet...",https://finnhub.io/api/news?id=23f8ab51fae0618fff9bc990186d549e78eb41db3e9ce63622e5952fb6c5ce2a
